METROPOLITAN LIFE INSURANCE CO/NY - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$79,173
-24.5%
4,936
+9.2%
0.00%
-20.0%
Q2 2023$104,797
-0.2%
4,5210.0%0.01%0.0%
Q1 2023$105,023
+44.5%
4,521
-9.8%
0.01%
+66.7%
Q4 2022$72,695
-24.0%
5,0100.0%0.00%
-40.0%
Q3 2022$95,591
+5.0%
5,0100.0%0.01%
+25.0%
Q2 2022$91,032
-27.9%
5,0100.0%0.00%
-20.0%
Q1 2022$126,252
-77.4%
5,010
-75.3%
0.01%
-37.5%
Q4 2021$559,314
-14.5%
20,2650.0%0.01%
-11.1%
Q3 2021$654,357
+6.3%
20,265
+0.6%
0.01%0.0%
Q2 2021$615,789
+5.3%
20,137
+4.9%
0.01%0.0%
Q1 2021$584,670
+33.6%
19,201
-13.3%
0.01%
+28.6%
Q4 2020$437,759
+51.6%
22,1370.0%0.01%
+40.0%
Q3 2020$288,666
+15.0%
22,1370.0%0.01%
+25.0%
Q2 2020$251,034
-20.8%
22,1370.0%0.00%
-42.9%
Q1 2020$316,780
-47.4%
22,1370.0%0.01%
-30.0%
Q4 2019$602,791
-6.8%
22,137
-2.0%
0.01%
-9.1%
Q3 2019$646,551
+3.1%
22,5830.0%0.01%0.0%
Q2 2019$627,356
-15.2%
22,583
+1.3%
0.01%
-15.4%
Q1 2019$740,094
+12.0%
22,292
-2.0%
0.01%0.0%
Q4 2018$661,023
-31.4%
22,739
+8.5%
0.01%
-23.5%
Q3 2018$963,608
-99.9%
20,9480.0%0.02%
+30.8%
Q2 2018$782,827,000
+26.5%
20,9480.0%0.01%
+44.4%
Q1 2018$619,014,000
+88078.6%
20,948
+2.5%
0.01%0.0%
Q4 2017$702,000
-54.6%
20,446
-52.1%
0.01%
-10.0%
Q3 2017$1,545,000
+35.2%
42,700
-3.5%
0.01%
+25.0%
Q2 2017$1,143,000
+24.2%
44,232
-7.7%
0.01%
+33.3%
Q1 2017$920,000
+11.7%
47,907
-3.1%
0.01%0.0%
Q4 2016$824,000
-19.0%
49,4310.0%0.01%
-14.3%
Q3 2016$1,017,000
-32.8%
49,4310.0%0.01%
-36.4%
Q2 2016$1,513,000
-18.2%
49,4310.0%0.01%
-21.4%
Q1 2016$1,850,000
-10.9%
49,431
+2.8%
0.01%
-12.5%
Q4 2015$2,076,000
+13.4%
48,090
-1.5%
0.02%
+23.1%
Q3 2015$1,830,000
+11.0%
48,834
+0.7%
0.01%
+8.3%
Q2 2015$1,648,000
+886.8%
48,471
+888.6%
0.01%
+1100.0%
Q4 2014$167,000
-9.2%
4,903
+2.6%
0.00%0.0%
Q3 2014$184,000
-1.6%
4,780
-0.5%
0.00%0.0%
Q2 2014$187,000
+6.2%
4,806
-6.5%
0.00%0.0%
Q1 2014$176,000
+63.0%
5,1420.0%0.00%0.0%
Q4 2013$108,000
-16.3%
5,142
-6.2%
0.00%0.0%
Q3 2013$129,000
-13.4%
5,479
-1.3%
0.00%0.0%
Q2 2013$149,0005,5530.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders